765 related articles for article (PubMed ID: 24533874)
1. IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.
Fokkink WJ; Selman MH; Dortland JR; Durmuş B; Kuitwaard K; Huizinga R; van Rijs W; Tio-Gillen AP; van Doorn PA; Deelder AM; Wuhrer M; Jacobs BC
J Proteome Res; 2014 Mar; 13(3):1722-30. PubMed ID: 24533874
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome.
Buchwald B; Ahangari R; Weishaupt A; Toyka KV
Ann Neurol; 2002 Jun; 51(6):673-80. PubMed ID: 12112071
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome.
Kuitwaard K; de Gelder J; Tio-Gillen AP; Hop WC; van Gelder T; van Toorenenbergen AW; van Doorn PA; Jacobs BC
Ann Neurol; 2009 Nov; 66(5):597-603. PubMed ID: 19938102
[TBL] [Abstract][Full Text] [Related]
4. Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy.
Wong AH; Fukami Y; Sudo M; Kokubun N; Hamada S; Yuki N
J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):275-9. PubMed ID: 25814494
[TBL] [Abstract][Full Text] [Related]
5. IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
Selman MH; Niks EH; Titulaer MJ; Verschuuren JJ; Wuhrer M; Deelder AM
J Proteome Res; 2011 Jan; 10(1):143-52. PubMed ID: 20672848
[TBL] [Abstract][Full Text] [Related]
6. Changes of Serum IgG Dimer Levels after Treatment with IVIg in Guillain-Barré Syndrome.
Svačina MKR; Röth P; Bobylev I; Sprenger A; Zhang G; Sheikh KA; Lehmann HC
J Neuroimmune Pharmacol; 2019 Dec; 14(4):642-648. PubMed ID: 31515689
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS).
van Doorn PA
Presse Med; 2013 Jun; 42(6 Pt 2):e193-201. PubMed ID: 23628447
[TBL] [Abstract][Full Text] [Related]
8. IVIg-induced plasmablasts in patients with Guillain-Barré syndrome.
Brem MD; Jacobs BC; van Rijs W; Fokkink WJR; Tio-Gillen AP; Walgaard C; van Doorn PA; IJspeert H; van der Burg M; Huizinga R
Ann Clin Transl Neurol; 2019 Jan; 6(1):129-143. PubMed ID: 30656191
[TBL] [Abstract][Full Text] [Related]
9. Association of Albumin Levels With Outcome in Intravenous Immunoglobulin-Treated Guillain-Barré Syndrome.
Fokkink WR; Walgaard C; Kuitwaard K; Tio-Gillen AP; van Doorn PA; Jacobs BC
JAMA Neurol; 2017 Feb; 74(2):189-196. PubMed ID: 28027337
[TBL] [Abstract][Full Text] [Related]
10. Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.
Walgaard C; Jacobs BC; Lingsma HF; Steyerberg EW; Cornblath DR; van Doorn PA;
J Peripher Nerv Syst; 2018 Dec; 23(4):210-215. PubMed ID: 30151941
[TBL] [Abstract][Full Text] [Related]
11. Change in IgG1 Fc N-linked glycosylation in human lung cancer: age- and sex-related diagnostic potential.
Chen G; Wang Y; Qin X; Li H; Guo Y; Wang Y; Liu H; Wang X; Song G; Li F; Li F; Guo S; Qiu L; Li Z
Electrophoresis; 2013 Aug; 34(16):2407-16. PubMed ID: 23766031
[TBL] [Abstract][Full Text] [Related]
12. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
13. Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc.
Anumula KR
J Immunol Methods; 2012 Aug; 382(1-2):167-76. PubMed ID: 22683540
[TBL] [Abstract][Full Text] [Related]
14. A close look at human IgG sialylation and subclass distribution after lectin fractionation.
Stadlmann J; Weber A; Pabst M; Anderle H; Kunert R; Ehrlich HJ; Peter Schwarz H; Altmann F
Proteomics; 2009 Sep; 9(17):4143-53. PubMed ID: 19688751
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumour necrosis factor alpha & soluble TNF receptors in patients with Guillain-Barre syndrome.
Radhakrishnan VV; Sumi MG; Reuben S; Mathai A; Nair MD
Indian J Med Res; 2003 May; 117():216-20. PubMed ID: 14609050
[TBL] [Abstract][Full Text] [Related]
16. High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides.
Baković MP; Selman MH; Hoffmann M; Rudan I; Campbell H; Deelder AM; Lauc G; Wuhrer M
J Proteome Res; 2013 Feb; 12(2):821-31. PubMed ID: 23298168
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Fc N-Glycosylation of Pharmaceutical Products of Intravenous Immunoglobulin G.
Fokkink WJ; Falck D; Santbergen TC; Huizinga R; Wuhrer M; Jacobs BC
PLoS One; 2015; 10(10):e0139828. PubMed ID: 26457892
[TBL] [Abstract][Full Text] [Related]
18. Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation.
Wuhrer M; Stavenhagen K; Koeleman CA; Selman MH; Harper L; Jacobs BC; Savage CO; Jefferis R; Deelder AM; Morgan M
J Proteome Res; 2015 Apr; 14(4):1657-65. PubMed ID: 25761865
[TBL] [Abstract][Full Text] [Related]
19. Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
Verboon C; van den Berg B; Cornblath DR; Venema E; Gorson KC; Lunn MP; Lingsma H; Van den Bergh P; Harbo T; Bateman K; Pereon Y; Sindrup SH; Kusunoki S; Miller J; Islam Z; Hartung HP; Chavada G; Jacobs BC; Hughes RAC; van Doorn PA;
J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):113-121. PubMed ID: 31586949
[TBL] [Abstract][Full Text] [Related]
20. Blood plasma IgG Fc glycans are significantly altered in Alzheimer's disease and progressive mild cognitive impairment.
Lundström SL; Yang H; Lyutvinskiy Y; Rutishauser D; Herukka SK; Soininen H; Zubarev RA
J Alzheimers Dis; 2014; 38(3):567-79. PubMed ID: 24028868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
